Royal Bank of Canada
NAUT icon

Royal Bank of Canada’s Nautilus Biotechnolgy NAUT Stock Holding History

Royal Bank of Canada’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Buy
11,207
+11,116
+12,215% +$29.3K ﹤0.01% 6314
2026
Q1 		$0 Sell
91
-3,183
-97% -$7.82K ﹤0.01% 7482
2025
Q4 		$6K Buy
3,274
+1,452
+80% +$2.38K ﹤0.01% 6652
2025
Q3 		$1K Sell
1,822
-482
-21% -$354 ﹤0.01% 7009
2025
Q2 		$1K Sell
2,304
-3,340
-59% -$2.51K ﹤0.01% 6908
2025
Q1 		$5K Sell
5,644
-2,345
-29% -$3.48K ﹤0.01% 6360
2024
Q4 		$13K Buy
7,989
+2,903
+57% +$6.94K ﹤0.01% 6272
2024
Q3 		$14K Sell
5,086
-455
-8% -$1.18K ﹤0.01% 6228
2024
Q2 		$13K Buy
5,541
+4,375
+375% +$11.4K ﹤0.01% 6246
2024
Q1 		$3K Sell
1,166
-15,512
-93% -$44K ﹤0.01% 6604
2023
Q4 		$50K Buy
16,678
+5,463
+49% +$15.6K ﹤0.01% 5996
2023
Q3 		$36K Buy
11,215
+5,938
+113% +$19.3K ﹤0.01% 5945
2023
Q2 		$20K Buy
5,277
+1,168
+28% +$3.37K ﹤0.01% 6215
2023
Q1 		$11K Sell
4,109
-2,836
-41% -$5.95K ﹤0.01% 6267
2022
Q4 		$12K Buy
6,945
+6,364
+1,095% +$12.3K ﹤0.01% 6477
2022
Q3 		$1K Buy
581
+311
+115% +$782 ﹤0.01% 7221
2022
Q2 		$1K Sell
270
-1,827
-87% -$6.8K ﹤0.01% 7155
2022
Q1 		$9K Buy
+2,097
New +$8.61K ﹤0.01% 7000

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Royal Bank of Canada's NAUT Position: Q2 2026 in Review

Royal Bank of Canada increased its Nautilus Biotechnolgy (NAUT) stake by 12,215% in Q2 2026, buying an estimated $29.3K and bringing the position to 11,207 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #6314.

Royal Bank of Canada first reported a position in NAUT in Q1 2022 and has held it in 18 quarters since. The position peaked at $50K in Q4 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Royal Bank of Canada held 11,207 shares of Nautilus Biotechnolgy worth $21K as of Q2 2026.
  • Royal Bank of Canada bought 11,116 Nautilus Biotechnolgy shares in Q2 2026, an estimated $29.3K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6314 holding.
  • Royal Bank of Canada first reported a position in Nautilus Biotechnolgy in Q1 2022 and has held it in 18 quarters since.
  • Royal Bank of Canada's Nautilus Biotechnolgy position peaked at $50K in Q4 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.